Screening for colorectal cancer by full colonoscopy in first-degree relatives of colorectal cancer patients: a multicentric study by the Italian League for the Fight against Cancer
Keywords:
Colorectal cancer; cancer screening; secondary prevention; colonoscopy; familial cancerAbstract
Background. Colorectal cancer currently presents the third-highest incidence of cancers worldwide, making secondary prevention through screening programs for colorectal cancer, usually by Fecal Occult Blood Testing, an essential preventive medicine intervention. First-degree relatives of colorectal cancer patients are a particularly at-risk group, with indications to consider direct screening by full colonoscopy. Colonoscopy is considered the gold standard for diagnosing colorectal cancer, as it has high sensitivity and specificity, and is both a diagnostic and therapeutic tool. However, it requires significant organizational and financial resources, and has a small but relatively higher risk of complications as opposed to fecal occult blood testing. The present study aimed to assess the appropriateness of a screening program without age restrictions of CRC by full colonoscopy in asymptomatic, first-degree adult relatives of patients with colorectal cancer, aiming both to actively increase screening coverage and to determine the detection rate of precancerous lesions and colorectal cancer in this population.
Study Design. Uncontrolled interventional study – colorectal cancer screening by full colonoscopy for at-risk population.
Methods. The Italian League for the Fight against Cancer started a colorectal cancer screening program by full colonoscopy for first-degree relatives of colorectal cancer patients in 1998 in the province of Latina, Lazio Region, Italy. The program was expanded to the provinces of Rieti, Lazio Region, and Sassari, Sardinia Region, in 2014 and 2016 respectively, and was concluded in 2018. Subjects were actively and voluntarily recruited by the study’s working group. Subjects that had already been subjected to a full colonoscopy in the preceding 5 years were excluded from this study. Identified neoplastic lesions were treated either directly or referred to the Day Hospital setting, and histologically diagnosed following World Health Organization guidelines.
Results. In total, 2,288 subjects (age range 15-88, mean 52.3 yrs, M/F = 946/1,204) were screened by colonoscopy, of which 103 (4.5%) were incomplete and 2,173 (95.0%) complete, with data on colonoscopy performance missing for 12 participants. Out of 468 positive outcomes on colonoscopy, diagnosis for 422 (204M/173F), 19.4% of total subjects, was adenomatous polyps and 46 (20M/20F), 2.1% of total subjects, was colorectal cancer. Female sex was a protective factor against a positive test outcome, with a 35% reduction compared to male sex, with OR=0.64 95%CI (0.52-0.80). On the other hand, being over 50 years of age was found to be a risk factor, making a positive outcome more than twice as likely, with OR=2.3 95%CI (1.8-2.9). Subjects over 50 also had significantly more instances of multiple adenomas being found, however the size distribution of found adenomas was not significantly different between subjects under and over 50, despite size being a predictor of risk of neoplastic progression.
Conclusions. Given the high detection rate of precancerous lesions and colorectal cancer in the studied population, it is our opinion that guidelines should continue to recommend earlier and more frequent screening in first-degree relatives of patients with colorectal cancer, and, barring the introduction of more cost-effective and/or lower risk procedures with a similar efficacy profile, maintain the use of colonoscopy as the main screening option.
References
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May; 71(3): 209-49. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2. AIRTUM Working Group. I Numeri del Cancro in Italia 2020 [Internet]. Brescia: Intermedia Editore; 2020 [cited 2023 May 15]. 11–28 p. Available from: [https://www.aiom.it/wp-content/uploads/2020/10/2020_Numeri_Cancrooperatori_web.pdf](https://www.aiom.it/wp-content/uploads/2020/10/2020_Numeri_Cancrooperatori_web.pdf) [Last accessed: 2023 December 05].
3. Pannozzo F, Macci L, Curatella S, Bernazza E, Bugliarello E. I Tumori in provincia di Latina Rapporto 2018 [Internet]. Latina: Registro Tumori di Popolazione della Provincia di Latina; 2018 [cited 2023 May 15]. 10–20 p. Available from: [https://www.registri-tumori.it/cms/sites/default/files/pubblicazioni/RTLT_2018_1.pdf](https://www.registri-tumori.it/cms/sites/default/files/pubblicazioni/RTLT_2018_1.pdf) [Last accessed: 2023 December 05].
4. AIRTUM Working Group. I Numeri del Cancro in Italia 2021 [Internet]. Brescia: Intermedia Editore; 2021 [cited 2023 May 15]. 50-52 p. Available from: [https://www.aiom.it/wp-content/uploads/2021/10/2021_NumeriCancro_web.pdf](https://www.aiom.it/wp-content/uploads/2021/10/2021_NumeriCancro_web.pdf) [Last accessed: 2023 December 05].
5. AIRTUM Working Group. I Numeri del Cancro in Italia 2022 [Internet]. Brescia: Intermedia Editore; 2022 [cited 2023 May 15]. 54-56 p. Available from: [https://www.aiom.it/wp-content/uploads/2022/12/2022_AIOM_NDC-web.pdf](https://www.aiom.it/wp-content/uploads/2022/12/2022_AIOM_NDC-web.pdf) [Last accessed: 2023 December 05].
6. Zorzi M, Cavestro GM, Guzzinati S, Dal Maso L, Rugge M; AIRTUM Working Group. Decline in the incidence of colorectal cancer and the associated mortality in young Italian adults. Gut. 2020 Oct; 69(10): 1902-3. doi: 10.1136/gutjnl-2019-320406. Epub 2019 Dec 16.
7. Gilbertsen VA, Nelms JM. The prevention of invasive cancer of the rectum. Cancer. 1978; 41(3): 1137-9. doi: 10.1002/1097-0142(197803)41:3<1137::aidcncr2820410350>3.0.co;2-g.
8. Greegor DH. Diagnosis of large-bowel cancer in the asymptomatic patient. JAMA. 1967 Sep 18; 201(12): 943-5.
9. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996 Nov 30; 348(9040): 1467-71. doi: 10.1016/S0140-6736(96)03430-7.
10. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 May 13; 328(19): 1365-71. doi: 10.1056/NEJM199305133281901.
11. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996 Nov 30; 348(9040): 1472-7. doi: 10.1016/S0140-6736-(96)03386-7.
12. Crotta S, Castiglione G, Grazzini G, Valle F, Mosconi S, Rosset R. Feasibility study of colorectal cancer screening by immunochemical faecal occult blood testing: results in a northern Italian community. Eur J Gastroenterol Hepatol. 2004 Jan; 16(1): 33-7. doi: 10.1097/00042737-200401000-00006.
13. Grazzini G, Castiglione G, Ciabattoni C, Franceschini F, Giorgi D, Gozzi S, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev Off J Eur Cancer Prev Organ ECP. 2004 Feb; 13(1): 19-26. doi: 10.1097/00008469-200402000-00004.
14. Grazzini G, Castiglione G, Isu A, Mantellini P, Rubeca T, Sani C, et al. Colorectal cancer screening by fecal occult blood testing: results of a population-based experience. Tumori. 2000; 86(5): 384-8. doi: 10.1177/030089160008600503.
15. Interventi urgenti per fronteggiare situazioni di pericolo per la salute pubblica [Internet]. Legge 138 May 26, 2004. Available from: [https://www.gazzettaufficiale.it/atto/serie_generale/caricaDettaglioAtto/originario?atto.dataPubblicazioneGazzetta=2004-05-29&atto.codiceRedazionale=04A05690&elenco30giorni=false](https://www.gazzettaufficiale.it/atto/serie_generale/caricaDettaglioAtto/originario?atto.dataPubblicazioneGazzetta=2004-05-29&atto.codiceRedazionale=04A05690&elenco30giorni=false) [Last accessed: 2023 December 05].
16. Carbone S, Campolongo A, Ceccolini C, Colandrea C, Di Fonzo G, Gallo M, et al. Monitoraggio dei LEA attraverso il Nuovo Sistema di Garanzia – Metodologia e risultati dell’anno 2020. Roma: Ministero della Salute - Direzione generale della programmazione sanitaria - Ufficio 6; 2023.
17. Osservatorio Nazionale Screening. Lo screening colorettale - Dati di attività dal 2014 al 2020 [Internet]. [cited 2023 May 15]. Available from: [https://www.osservatorionazionalescreening.it/content/lo-screening-colorettale](https://www.osservatorionazionalescreening.it/content/lo-screening-colorettale) [Last accessed: 2023 December 05].
18. OECD. Health at a Glance 2019: OECD Indicators [Internet]. Paris: Organisation for Economic Co-operation and Development; 2019 [cited 2023 May 15]. Available from: [https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2019_4dd50c09-en](https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2019_4dd50c09-en) [Last accessed: 2023 December 05].
19. Ponz de Leon M, Rossi G, di Gregorio C, De Gaetani C, Rossi F, Ponti G, et al. Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. Intern Emerg Med. 2007 Dec 1; 2(4): 269-79. doi: 10.1007/s11739-007-0077-z. Epub 2007 Nov 29.
20. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med. 1994 Dec 22; 331(25): 1669-74. doi: 10.1056/NEJM199412223312501.
21. Guttmacher AE, Collins FS, Carmona RH. The family history--more important than ever. N Engl J Med. 2004 Nov 25; 351(22): 2333-6. doi: 10.1056/NEJMsb042979.
22. Butterworth AS, Higgins JPT, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer Oxf. 1990. 2006 Jan; 42(2): 216-7. doi: 10.1016/j.ejca.2005.09.023. Epub 2005 Dec 9.
23. Song M, Emilsson L, Roelstraete B, Ludvigsson JF. Risk of colorectal cancer in first degree relatives of patients with colorectal polyps: nationwide case-control study in Sweden. BMJ. 2021 May 4; 373: n877. doi: 10.1136/bmj.n877.
24. Gruppo di Lavoro per lo Screening del Carcinoma del Colon Retto. Raccomandazioni per lo Screening del Carcinoma del Colon Retto. In: Ministero della Salute - Raccomandazioni per la pianificazione e l’esecuzione degli screening di popolazione per la prevenzione del cancro della mammella, del cancro della cervice uterina e del cancro del colon retto. Rome: Tipografia Graffiti; 2006: 55-74.
25. Cheng TI, Wong JM, Hong CF, Cheng SH, Cheng TJ, Shieh MJ, et al. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests. J Formos Med Assoc Taiwan Yi Zhi. 2002 Oct; 101(10): 685-90.
26. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005 Aug; 129(2): 422-8. doi: 10.1016/j.gastro.2005.05.056.
27. Winawer SJ, Zauber AG, Ho MN, Ho MN, O’Brien MJ, Gottlieb LS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993 Dec 30; 329(27): 1977-81. doi: 10.1056/NEJM199312303292701.
28. Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol. 1999 Apr; 34(4): 414-20. doi: 10.1080/003655299750026443.
29. Scintu F, Canalis C, Capra F, D’Alia G, Giordano M, Mocci P, et al. [Colonoscopic screening in first-degree relatives of patients with sporadic colorectal cancer]. Ann Ital Chir. 2000; 71(6): 693-9. Italian.
30. Lieberman DA, Weiss DG; Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001 Aug 23; 345(8): 555-60. doi: 10.1056/NEJMoa010328.
31. Sinnona N, Pacchiarotti A, Rossi A, Cecconi A, Angelini F. Secondary prevention of colorectal cancer conducted by the Italian League for the Fight against Cancer in the Province of Latina, Italy. Preliminary results. Eur J Oncol Environ Health. 2008 Mar; 13(1): 41-6.
32. Nelson DB, McQuaid KR, Bond JH, Lieberman DA, Weiss DG, Johnston TK. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc. 2002 Mar; 55(3): 307-14. doi: 10.1067/mge.2002.121883.
33. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000 Jul 20; 343(3): 162-8. doi: 10.1056/NEJM200007203430301.
34. Pezzoli A, Matarese V, Rubini M, Simoni M, Caravelli GC, Stockbrugger R, et al. Colorectal cancer screening: results of a 5-year program in asymptomatic subjects at increased risk. Dig Liver Dis. 2007 Jan; 39(1): 33-9. doi: 10.1016/j.dld.2006.09.001.
35. Thiis-Evensen E, Hoff GS, Sauar J, Vatn MH. Patient tolerance of colonoscopy without sedation during screening examination for colorectal polyps. Gastrointest Endosc. 2000 Nov; 52(5): 606-10. doi: 10.1067/mge.2000.109804.
36. Rutter CM, Johnson E, Miglioretti DL, Mandelson MT, Inadomi J, Buist DSM. Adverse Events after Screening and Follow-up Colonoscopy. Cancer Causes Control. 2012 Feb; 23(2): 289-96. doi: 10.1007/s10552-011-9878-5.
37. Kim SY, Kim HS, Park HJ. Adverse events related to colonoscopy: Global trends and future challenges. World J Gastroenterol. 2019 Jan 14; 25(2): 190-204. doi: 10.3748/wjg.v25.i2.190.
38. Benazzato L, Zorzi M, Antonelli G, Guzzinati S, Hassan C, Fantin A; Veneto Screening Endoscopists Working Group. Colonoscopy-related adverse events and mortality in an Italian organized colorectal cancer screening program. Endoscopy. 2021 May; 53(5): 501-8. doi: 10.1055/a-1228-9225.
39. Pariente A, Milan C, Lafon J, Faivre J. Colonoscopic screening in first-degree relatives of patients with “sporadic” colorectal cancer: a case-control study. The Association Nationale des Gastroentérologues des Hôpitaux and Registre Bourguignon des Cancers Digestifs (INSERM CRI 9505). Gastroenterology. 1998 Jul; 115(1): 7-12. doi: 10.1016/s0016-5085(98)70358-0.
40. Guillem JG, Neugut AI, Forde KA, Waye JD, Treat MR. Colonic neoplasms in asymptomatic first-degree relatives of colon cancer patients. Am J Gastroenterol. 1988 Mar; 83(3): 271-3.
41. Baker JW, Gathright JB, Timmcke AE, Hicks TC, Ferrari BT, Ray JE. Colonoscopic screening of asymptomatic patients with a family history of colon cancer. Dis Colon Rectum. 1990 Nov; 33(11): 926-30. doi: 10.1007/BF02139100.
42. Armelao F, Paternolli C, Franceschini G, Franch R, Orlandi PG, Miori G, et al. Colonoscopic findings in first-degree relatives of patients with colorectal cancer: a population-based screening program. Gastrointest Endosc. 2011 Mar; 73(3): 527-34.e2. doi: 10.1016/j.gie.2010.12.025.
43. Del Vecchio Blanco G, Cretella M, Paoluzi OA, Caruso A, Mannisi E, et al. Adenoma, advanced adenoma and colorectal cancer prevalence in asymptomatic 40- to 49-year-old subjects with a first-degree family history of colorectal cancer. Colorectal Dis. 2013 Sep; 15(9): 1093-9. doi: 10.1111/codi.12263.
44. Castiglione G, Visioli CB, Zappa M, Grazzini G, Mallardi B, Mantellini P. Familial risk of colorectal cancer in subjects attending an organised screening programme. Dig Liver Dis. 2012 Jan; 44(1): 80-3. doi: 10.1016/j.dld.2011.08.007. Epub 2011 Sep 16.
45. Ruthotto F, Papendorf F, Wegener G, Unger G, Dlugosch B, Korangy F, et al. Participation in screening colonoscopy in first-degree relatives from patients with colorectal cancer. Ann Oncol. 2007 Sep 1; 18(9): 1518-22. doi: 10.1093/annonc/mdm200.
46. Alkatout I, Biebl M, Momenimovahed Z, Giovannucci E, Hadavandsiri F, Salehiniya H, et al. Has COVID-19 Affected Cancer Screening Programs? A Systematic Review. Front Oncol. 2021; 11: 675038. doi: 10.3389/fonc.2021.675038.
47. Mayo M, Potugari B, Bzeih R, Scheidel C, Carrera C, Shellenberger RA. Cancer Screening During the COVID-19 Pandemic: A Systematic Review and Meta-analysis. Mayo Clin Proc Innov Qual Outcomes. 2021 Dec; 5(6): 1109-17. doi: 10.1016/j.mayocpiqo.2021.10.003.
48. Buscarini E, Benedetti A, Monica F, Pasquale L, Buttitta F, Cameletti M, et al. Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey. Dig Liver Dis. 2021 Jun; 53(6): 682-8. doi: 10.1016/j.dld.2021.02.021.
49. Fancellu A, Veneroni S, Santoru A, Meloni A, Sanna V, Ginesu GC, et al. How the COVID-19 pandemic has affected the colorectal cancer screening in Italy: A minireview. World J Gastrointest Oncol. 2022 Aug 15; 14(8): 1490–8. doi: 10.4251/wjgo.v14.i8.1490.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.